FDA.reportPublic FDA data

cabergoline 0.5 MG Oral Tablet

RxCUI
199703
RxNorm name
cabergoline 0.5 MG Oral Tablet
Display name
cabergoline 0.5 MG Oral Tablet
Full name
cabergoline 0.5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CabergolineCABERGOLINEMylan Pharmaceuticals Inc.e497366b-a124-4d7f-bd45-a883c392d4bb2026-06-30Warnings, Adverse reactionsExact identifier
rxcui: 199703
CABERGOLINECABERGOLINECranbury Pharmaceuticals, LLC8562f94f-a59a-4893-aefc-ea6547b01e922026-06-22Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutionsc9f0b576-d5e5-4e3e-bb5c-3574d75d99072026-03-19Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINESOLA Pharmaceuticals, LLC275a6a25-c3c9-4258-a610-0b00752517f72025-12-08Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutions9405c116-4a77-4e14-9ab8-25e899595cdf2025-08-27Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEIngenus Pharmaceuticals, LLC57cbd81e-fdb9-4060-80ee-6e8581c463a42025-07-04Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINETeva Pharmaceuticals USA, Inc.74b61e8a-7ae9-4996-85ec-df23c56de16f2025-06-16Warnings, Adverse reactionsExact identifier
rxcui: 199703
CABERGOLINECABERGOLINESomerset Therapeutics, LLCe0fb5556-de2c-4822-9960-0700e29078902024-11-14Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEAmneal Pharmaceuticals NY LLCa246b015-e19c-4b4f-9089-aea1108687ba2024-10-03Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutions7699d938-3f62-4e13-9b33-3e581310b9f32023-08-28Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.bc44d11b-b3f0-4e3d-9da3-4f8852d117342023-07-27Warnings, Adverse reactionsExact identifier
rxcui: 199703
CabergolineCABERGOLINEA-S Medication Solutions89ec147b-a6fe-49bb-9af5-52fc2ce5db7f2023-04-12Warnings, Adverse reactionsExact identifier
rxcui: 199703

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 14 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
74b61e8a-7ae9-4996-85ec-df23c56de16fcabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]221These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250616
57cbd81e-fdb9-4060-80ee-6e8581c463a4cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]212These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250704
e497366b-a124-4d7f-bd45-a883c392d4bbcabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use CABERGOLINE safely and effectively. See full prescribing information for CABERGOLINE. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620250930
c9f0b576-d5e5-4e3e-bb5c-3574d75d9907cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]210These highlights do not include all the information needed to use CABERGOLINE TABLETS safely and effectively. See full prescribing information for CABERGOLINE TABLETS. CABERGOLINE tablets, for oral use Initial U.S. Approval: 199620260319
89ec147b-a6fe-49bb-9af5-52fc2ce5db7fcabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]26Cabergoline Tablets, USP20230412
518d43ee-8d33-4abd-96a5-1b6890e59b08cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]25CABERGOLINE TABLETS, USP Rx only20250401
275a6a25-c3c9-4258-a610-0b00752517f7cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]24CABERGOLINE TABLETS Rx only20251208
e0fb5556-de2c-4822-9960-0700e2907890cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]24Cabergoline Tablets, USP20241114
c85d676c-e23e-468d-9de3-79202d9fad3fcabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]24Cabergoline Tablets20200118
bc44d11b-b3f0-4e3d-9da3-4f8852d11734cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]22CABERGOLINE TABLETS, USP Rx only20230727
9405c116-4a77-4e14-9ab8-25e899595cdfcabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]21Cabergoline Tablets, USP Rx only20250827
a246b015-e19c-4b4f-9089-aea1108687bacabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]21Cabergoline Tablets, USP Rx only20241003
67db5c74-b0f8-4684-b025-d4c9837c62b6cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]21Cabergoline Tablets, USP Rx only20240708
7699d938-3f62-4e13-9b33-3e581310b9f3cabergoline 0.5 MG Oral Tablet [PSN] · cabergoline 0.5 MG Oral Tablet [SCD]21CABERGOLINE TABLETS, USP Rx only20230828